Patient-reported Outcomes in Lymphoma Clinical Trials Are Recognized as Important Tools
News
Patient-reported outcomes in clinical trials of brentuximab vedotin for Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) show improvements in patients’ health-related quality of life, emphasizing their importance for patient management ... Read more